Forty-four cases of myelodysplasia in children were studied.
Introduction lished as single reports. [12] [13] [14] [15] In the absence of widely accepted inclusion criteria in Myelodysplasia is a well-known entity in adults but less well childhood MDS, we defined that inclusion in the study recognized in children, except in the context of specific disimplied that the patient have had the following signs for more eases such as Fanconi anaemia. Its frequency remained than 2 months: (1) cytopenia (defined as follows: neutropenia: unknown until recently, where its annual incidence has been Ͻ1.5 × 10 9 /l if under 6 months of age, Ͻ1 × 10 9 /l between 6 estimated at 4 × 10 −6 (9% of haematological malignancies in months and 4 years, Ͻ1.5 × 10 9 /l for older patients; anaemia: children) in a population-based survey. 1 Hb Ͻ11 g/dl if under 6 years, Ͻ12 g/dl otherwise; thrombo-FAB classification for myelodysplastic syndromes (MDS), 2 cytopenia: Ͻ150 × 10 9 /l) of at least two lineages, and/or based on criteria defined for adult cases, is used worldwide (2) unexplained macrocytosis (Ͼ100 fl under 6 months, Ͼ85 fl for adult MDS. However, this classification is not applicable when 6 months to 6 years old, Ͼ90 fl after), and/or (3) bone to all cases of childhood MDS. [3] [4] [5] [6] [7] [8] [9] marrow dystrophia of at least one lineage. These inclusion Literature on childhood MDS is relatively scarce, with only criteria allowed us to discard cases of virus-related bone mara very few large studies, heterogeneous as: (1) inclusion crirow failure, acquired aplastic anaemia, and colabamin or folteria are variable from one study to another, some studies ate deficiencies. On the contrary, it made it possible to including overlapping myeloproliferative cases or acute leuinclude true myelodysplastic cases even with unusual feakaemia cases; (2) classification systems are variable ('infantile tures, such as hypoplastic MDS, or various cytopenias with monosomy 7 syndrome' (IMo7 or Mo7), 'juvenile chronic hypercellular bone marrow, whatever their etiology. Cases myelogenous leukaemia' (JCML), and herein 'Non-FAB cases ') were therefore included (ie classified as MDS) on the grounds and none is universally accepted; and (3) some studies are of presenting cytological features, irrespective of clonality restricted to a given specific entity, selection biases are major, study results. and results are therefore difficult to compare. Thus, large studBone marrow smears, and when available, biopsy speciies of childhood MDS, with precisely and thoroughly defined mens, were reviewed by the Groupe Français d'Hématologie inclusion criteria, need to be reported.
Cytologique. The FAB criteria for the classification of myelo-MDS in children can occur: (1) without any known predysplastic syndromes were used for the diagnosis of: refractory disposing condition ('idiopathic' MDS); (2) after chemo/ anaemia (RA), refractory anaemia with ringed sideroblasts radiotherapy; or (3) on a pre-existing genetic background, the (RARS), refractory anaemia with excess of blasts (RAEB), latter being very diverse, including various Mendelian or mitorefractory anaemia with excess of blasts in transformation chondrial inherited traits, chromosomal anomalies, and mis-(RAEBT), chronic myelomonocytic leukaemia (CMML), and, finally, non-classifiable cases according to criteria originally defined for adult cases (herein called Non-FAB).
A pathogeny was searched for and cases were accordingly associated with a constitutional genetic disease. Main data are abnormalities. Whenever needed, a search for possible chromosome instability syndrome was performed: spontaneous presented in Table 1 , where patients were numbered according to age at diagnosis of MDS, and classified in the three breaks, breaks induced by mechlorethamine hydrochloride or by mitomycin C, sister chromatid exchange scorings, and/or pathogeny groups above mentioned.
For cytogenetic studies, karyotypes were obtained from cell cycle studies were assayed. Fluorescent in situ hybridization was performed in only a few cases for monosomy 7 bone marrow and/or blood samples, and results were reviewed according to our usual procedure in regional and research, and did not uncover yet undetected cases. Clonality was checked in five female patients with a normal national workshops. A constitutional karyotype was requested to assess normality or detect constitutional chromosome karyotype (cases 9, 17, 19, 33 and 36) as described in Allen et al, 16 using differential methylation near the polymorphic
According to age at diagnosis CAG repeat in the human androgen receptor gene on X chromosome; Allen's primers were used, primer 1 being fluorMedian age at diagnosis was around 4 years in this study, and varied from 2 to 5 years in most large reports, 1, 5, 7, 19 except in escein labelled without radioactivity.
Statistical analyses were performed using Fisher's exact test, one study (11 years in Creutzig et al). 17 We found a well balanced sex ratio in each age category and for comparisons between survivals, log-rank test, when not otherwise specified.
(Ͻ2 years, 2-5 years, Ͼ7 years). Patients aged Ͻ2 years had RAEB ± T less often (P = 0.03), and patients Ͻ1 year of age were frequently diagnosed as Non-FAB, but this latter result was not significant (P = 0.07). Other studies have found Results and discussion CMML associated with a very young age (median age: 9-13 months); 1,7 our number of CMML is too small for conclusions. There were 44 patients (20 males and 24 females) with a Median survival for patients aged Ͻ5 years and patients aged median age of 49-52 months (range: 1 month-15 years), eight Ͼ7 years were respectively 4 years and 2 years, and only one cases were infant cases (Ͻ1 year) ( Figure 1 ). Anaemia was fourth of patients aged Ͼ7 years were still alive at 4 years found at diagnosis in 43 of 44 cases, neutropenia in 27, follow-up (P Ͻ 0.02 vs younger patients; Figure 2b ). There thrombocytopenia in 34, macrocytosis in 12, and bone marwas no significant difference between patients aged Ͻ2 years row dystrophia in 25 cases.
and aged 2-5 years. Diagnosis of RA was made in five (11%) instances, RARS in two (4%), RAEB in 11 (25%), RAEBT in five (11%), CMML in six (14%), and Non-FAB in 15 (34%), which implies that
According to pathogeny about a third of the cases did not fulfill the available classification. As previously noted, RARS, a common finding in Idiopathic MDS: Apparently idiopathic MDS was found in adult MDS, is exceptionally encountered in children and so 25 (57%) cases (12 males/13 females), aged 52 months far mainly (but not only 7 ) in mitochondrial cytopathies. 8 The median (range: 4-179 months). Diagnosis was RA in three relative frequency of FAB categories is unknown and variable cases, RARS in one, RAEB in six, RAEBT in three, CMML in according to the studies; for instance, CMML has been diagsix, and Non-FAB in the remaining six patients. CMML was nosed in 5 to 10% of cases in some studies, 5, 17, 18 and in up significantly associated with idiopathic MDS (P = 0.03). The to a third or half of the cases in other reports. 1, 7, 19 This variakaryotype was normal in half (12 cases), showed monosomy bility may be due to selection bias. 20 7 in seven, trisomy 8 in three, and other anomalies in three Bone marrow transplantation (BMT) was performed in 22 cases; karyotype evolution occurred four times. Median surpatients. Most still-alive patients have a follow-up of 4 years vival in idiopathic MDS was 3 years, and one third of the or more (Table 1) .
patients was still alive at 5 years follow-up (Table 1) . Clonality was studied in cases 9 and 36 with a normal karyotype, as described above, and polyclonality was found According to sex in both cases, making it unlikely that myelodysplasia was a malignant process in these two patients. On the other hand, repeated tests confirmed the absence of infection history that Sex ratio was found to be balanced in this study, as in Brandcould have accounted for myelodysplastic features. They are wein et al, 19 in contrast to the male predominance (1.3:1 to both alive at 66 months+ and 98 months+. Myelodysplasia in 2.1:1) described in most studies. 1, 5, 7, 17 However, male prethese two cases may have an undetected genetic origin (see dominance was said in some reports to be restricted to RAEB, discussion further). Of note in this context is also case 6, an with or without transformation (called RAEB ± T in this infant girl who presented with cytopenia of the three lineages. paper), 1 or to CMML cases, 7 and that sex ratio is otherwise Bone marrow was found dystrophic with normal cellularity. balanced.
RAEB was diagnosed. The bone marrow karyotype was norMedian survival in male patients was 20 months. The 4 year mal. Viral, toxic, nutritional or metabolic aetiologies were dissurvival was 23% in male vs 56% in female patients carded. There was no genetic background of note (no con-(P Ͻ 0.01; Figure 2a) sanguinity, no associated malformation or immune deficiency, no sign of chromosome instability syndrome). The patient received two blood transfusions. Gammaglobulins were essayed, but without notable efficiency. However, blood data progressively returned to normal after 18 months follow-up. The patient is now considered to be cured spontaneously with a 6 year follow-up.
Secondary MDS: There were four (9%) cases with a history of either ependymoma, acute lymphoblastic leukaemia, Hodgkin disease, or neuroblastoma, 23-91 months before diagnosis ( Table 1) . The association RAEB ± T/secondary MDS was non-random (P = 0.01). Chromosome anomalies which were found (−7, del(5q) and t(8;21)) are known to occur in therapy-related leukaemias. Karyotype evolution during the course of the disease was found in the del(5q) case. Prognosis
Figure 1
Age at diagnosis of a myelodysplastic syndrome in 44 children.
was poor (Table 1) .
MDS with genetic background:
Fifteen cases (34%) were for the diagnosis of MDS were only met after more than 14 years of follow-up. The parents were first cousins. There were found associated with a (constitutional) genetic disease.
Shwachman syndrome was found in two cases. Shwachman two (of three) affected siblings. Shwachman syndrome, ICF syndrome, and Pearson syndrome diagnoses were discarded syndrome (MIM: Mendelian Inheritance in Man 21 26040) is an autosomal recessive condition with onset in childhood, in this patient. Transmission mode in case 20 is unclear. Various inheritsometimes in infancy, characterized by exocrine pancreas insufficiency with fatty replacement and pancytopenia; bone ance modes have been found to be associated with familial MDS, including autosomal recessive, and mitochondrial (see marrow may be rich, with an arrest in maturation, or hypoplastic. Immune deficiency is associated. Death is often due above); X-linked, autosomal dominant, and polygenic inheritances have also been suspected. 26 Among the various types to infections. Our cases (Nos 12 and 40, Table 1 ) both presented with anaemia and neutropenia at diagnosis, one of of familial MDS is familial monosomy 7, sometimes accompanied with ataxia. This entity may also be heterowhom also presented with thrombocytopenia and macrocytosis. A few cases of Shwachman syndrome with haematogeneous, as the transmission mode is arduous to determine (reviewed in Gilchrist et al 27 ). Familial monosomy 7 manifests logic malignancies have been documented (Refs 7, 22, present report): myelodysplasia (RA, RAEB ± T, CMML, Nonlater in childhood than infantile monosomy 7 syndrome (IMo7), 3, 11 and sex ratio is balanced in familial monosomy FAB), acute non-lymphocytic leukaemia (ANLL, often with a preceding MDS), and acute lymphocytic leukaemia (ALL) may 7. 11 Monosomy 7 has been found in some instances to be familial at the time of the karyotypic examination of an apparoccur in childhood, especially, so far, in male patients, at various ages. Prognosis seems poor, but the population sample is ently healthy potential bone marrow donor for a sibling with MDS and monosomy 7.
11,19
still very small. Mitochondrial diseases: there was one case of Pearson disUnbalanced constitutional karyotypes were found in three patients, each of whom was accompanied with the characterease, and another case of mitochondrial cytopathy (complex 1 and 4 deficiency in myocytes and fibroblasts). Pearson disease istic phenotype usually associated with these anomalies; there was a del(11)(q23) case (the phenotype was similar to that (MIM 26056) was thought to be autosomal recessive until this disease was recognized as a mitochondrial cytopathy, 23 also described in Penny et al 28 ), a del(21)(q21q22) patient, 14 and a patient with trisomy 21, who also presented with spontaneous with exocrine pancreas insufficiency, but with fibrosis, anaemia with ringed sideroblasts and vacuolization of precursor chromosome instability (of unknown origin) at repeated examinations. MDS in this latter patient may rather be related to cells, muscular and other ubiquitous manifestations as often in mitochondrial cytopathies. Our patient presented with anathe chromosome instability than to the Down syndrome.
As unbalanced karyotypes at birth account for roughly 0.4% emia, thrombocytopenia and bone marrow dystrophia. The patient died of an unknown cause. Our second case of mitoof the general population, the finding of three such cases out of 44 cases of childhood MDS cannot be coincidental. As a chondrial cytopathy had a normal karyotype, and a 62 months+ survival. Polyclonality was found in this patient; matter of fact, thrombocytopenia is a well-known finding both in patients with del(11q) syndrome 28 and in those with these and other reported cases of mitochondrial cytopathy with MDS ascertain the existence of true myelodysplasia (if del(21q) syndrome, 14 so that genes implicated in multipotent hematopoietic progenitor maturation and/or in megamyelodysplasia is defined according to given cytological features) although of non-malignant origin. However, the karyocytic differentiation have been suggested to lie distal to D11S1351 on chromosome 11q24q25, 28 and within prognosis may, none the less, be very poor. 8 It has been considered that RARS is so rare in childhood MDS that the diag21q22.1. 29 Down syndrome (DS) is known to be at high risk of M7 ANLL, often with a preceding pre-leukaemic phase. 30 nosis of mitochondrial cytopathy should be evoked when RARS is found in a child. 8 The recently described MDS in DS
1 is yet to be documented as to whether M7 ANLL will occur during follow-up of MDS in chromosome instability syndrome was found in two Fanconi anaemia (FA) boys with pancytopenia and macrothese patients.
Other MDS with 'some genetics': three additional female cytosis in one and bone marrow dystrophia in the other. A 15 000-fold increased risk of MDS and ANLL has been evalupatients (cases 1, 14, 35, Table 1 ) had various unspecific traits of dysmorphia (eg low set ears), and a constitutional genetic ated in FA, and it has been assumed that 'it is reasonable to regard the Fanconi anemia genotype as "preleukemia"' (Ref.
disease is likely to be present in these cases. Altogether, a constitutional genetic origin of the MDS, or at 24, see also Ref. 25 for review). That only two cases of FA were found during our prospective study was unexpected.
least, a genetic association, was found in one-third (15 of 44) of the cases; a similar frequency (28-30%) was reported by Other familial MDS: there were three other cases of familial MDS in female patients: case 19 suffered from Dubowitz synothers; 1,7 it may well be that a proportion of the so-called idiopathic cases are also of genetic origin, and special attention drome, an autosomal recessive disorder (MIM 22337) with dwarfism, microcephaly and mental retardation that may should be paid to these cases to detect/discover genetic diseases with bone marrow dysfunction proneness. clinically be confused with Bloom syndrome (BS), but without the typical chromosomal instability found in BS. This case has Of these 15, five were male and 10 female patients (nonsignificant), to be compared with 12 male and seven female been published in Bader-Meunier et al, 12 who found that blood cells in this patient were polyclonal; the authors sugpatients in another large study; 7 mean age at diagnosis (3 years) was equivalent in the two studies. In contrast with the gested, in consequence, that myelodysplasia may well not be a malignant phenomenon in this disease, but more likely be poor survival reported in Passmore et al, 7 median survival in this study was 5 years; nevertheless, a significant difference part of a multi-tissue deficiency. The paternal brother and sister of case 20 both died from blood malignancy when aged between this category and the idiopathic category was not found. However, the genetic group is heterogeneous -as the 15-17 years. Case 43 presented with congenital abnormalities (case fully reported in Stoll et al; 15 new data is that chronic idiopathic MDS group certainly is -and each disease must have a distinctive prognosis. Knowledge on this matter will myelogenous leukaemia was recently diagnosed in the father's sister). She had had neutropenia since birth, but full criteria necessitate much larger series to be conducted.
Other constitutional conditions predisposing to MDS in atic'. 11 However, cases of JCML without visible monosomy 7 appear to have no loss of heterozygosity (ie no submicrochildhood appear to be: Bloom syndrome, Kostmann syndrome, familial platelet storage pool deficiency, type 1 neuroscopic deletion) on chromosome 7.
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Thirty-eight percent of our patients with monosomy 7 were fibromatosis (Recklinhausen) often presenting with CMML and monosomy 7, 'immunodeficiency', other familial leukemias still alive at 3 years follow-up. Survival was better in patients with normal karyotype than in patients with monosomy 7 of yet undetermined origin (with various inheritance modes), including familial bone marrow monosomy 7 with or without (P Ͻ 0.04 at 2 years, Ͻ 0.01 at 3 years); however, patients with an abnormal karyotype but without monosomy 7 had an cerebellar ataxia, constitutional trisomy 8, other balanced or unbalanced chromosomal abnormalities, and miscellaneous even worse outcome (median survival 15 months): survival in this latter group was significantly shorter than in the normal conditions. 1, 3, 7, 8, 11, 20 karyotype group (P Ͻ 0.0001 at 2 years), and was also shorter, at near significance (P = 0.07), than in the monosomy 7 group (Figure 2c ). Hasle 20 found that monosomy 7 in childhood According to diagnosis MDS may be associated with a relatively long median survival (Table 2) , whereas this anomaly bears a severe prognosis in The few cases of RA or RARS had favourable outcomes (Table 1) ; median survival was 2.5 years in CMML cases, and adults. In a study on five children with various MDS, monosomy 7 was found to affect a myeloid progenitor, but not the 1.5 years in RAEB ± T cases, while the 5 year survival in Non-FAB cases was 50%, although no significant difference lymphoid precursor cells. 34 between RAEB ± T and Non-FAB cases could be evidenced. Median survival was found equivalent (and short: Ͻ1 year) in all FAB categories by some authors, 5 while, for others, 7 Other anomalies: There were three cases of trisomy 8 in idiopathic MDS in patients aged 90-171 months, with a poor JCML had the worst prognosis, IMo7 an intermediate one, and RA a better one. The situation may be even more complex, survival (1, 23+, 26 months); including cases from the literature, 7, 10, 17, 19, 35, 36, 37 15 cases with survival data were found; as it has been shown that different subgroups of patients, 'one with very rapid, and another with a much slower rate of mormedian survival was 10 months; this anomaly bears a severe prognosis in childhood MDS, as is known for adults. tality' 31 may exist within a given disease (CMML). Cases of RAEB ± T were older (P = 0.02), and more often had an abnorIn two cases an acquired trisomy 21 was restricted to the malignant clone. This was associated with the diagnosis of RA mal karyotype (P = 0.04). 'Non-FAB' was more often diagnosed in genetic MDS (P = 0.01).
(P = 0.01). Including cases in the literature, 9,17,18,19,37,38 eight documented cases (4 M/4 F), aged 0-15 years, with monosomy 7 in half, are available.
Two del(5q) and two t(8;21) occurred in 88-173 month old
According to the karyotype children with RAEB ± T, twice secondary, and with poor survivals (15, 15, 16, and 62+ months). To our knowledge, only Normal karyotype:
A normal karyotype was found in 20 (45%) cases (8 M/12 F), aged 34 months median (range: 1-one case of t(8;21), with RAEB, 9 and three instances of del(5q) 7, 32 have been described in childhood MDS, in contrast 179); a normal karyotype was frequently found in children Ͻ5 years, but this did not reach significance (P = 0.08). There with adult cases. Unbalanced t(1;7)(q10;p10) is known to occur in adults were four RA, two RARS, three RAEB, one RAEBT, two CMML and eight Non-FAB. The association between a normal karyowith MDS or ANLL, often secondary to a genotoxic exposure. It has, however, to our knowledge only been described in four type and the diagnosis of RA was close but not significant (P = 0.12). Sixty percent of patients with a normal karyotype children aged 1.5, 11, 14 and 15 years, and three adolescents aged 16-17 years (Refs 19, 37, 39, 40, 41 and present report). were still alive at 4 years follow-up. Information from the literature is scarce. Hasle 20 reviewed 65 cases with cytoThere was male predominance (6 M/1 F), and accompanying trisomy 8 in six of seven cases; in adults as well, unbalanced genetic studies, and found 31% of cases with a normal karyotype: median age was 10 years, sex ratio was balanced in this sex ratio and coexistent +8 are usually associated with t(1;7), but in contrast with adult cases, none of the seven group; median survival was only 24 months, in contrast with our results.
Monosomy 7:
Cases were 13 at diagnosis, and two additional cases occurred during evolution, sex ratio was balanced (8 M/7 F), median age was 34 months (2-117); diagnosis was RA in two cases, RAEB in four, RAEBT in two, CMML in four, and Non-FAB in three. Monosomy 7 and CMML were often associated in this study, but with no statistical significance (P ϭ 0.09).
For some authors, the diagnosis of IMo7 should be made in the case of a patient aged Ͻ4 years, with monosomy 7, in any FAB class (often a CMML), whereas the diagnosis of JCML applies to cases of CMML with fetal hemoglobin Ͼ10%, and with no monosomy 7; the remaining CMML are diagnosed as CMML. 7 For others, a monosomy 7 does not exclude the prognosis) and 'distinguishing Mo7 from JCML is problem- children/adolescent cases was secondary. Survival data were drawn from short follow-up; and (2) the still poor prognosis associated with MDS in children; survival was 80% at 1 year, available in only four cases (1, 6, 6, 17+ months).
Other karyotypes were found in six of our patients. There 60% at 2 years, 50% at 3 years, 40% at 4 years, 35% at 6 years. On the other hand, the remaining third of patients may was one case (No. 21) with a complex karyotype in RAEB which evolved towards acute leukaemia + lymphoma and probably be considered as cured. Fifteen of our patients have had a follow-up exceeding 4 death at 21 months.
Other recurring anomalies in childhood MDS appear to be years, and 17 died within 2 years after diagnosis (Table 3) . Age was lower in the long survivors group (P Ͻ 0.03, Wil-+19 (four cases only, 5, 19, 42, 43 but with very poor survival: 5, 6, 7, 9 months), del(6q) (five cases: (Refs 9, 10, 19, 44, and coxon non-parametric test), confirming the above findings using another procedure, and sex ratio was unbalanced in the ours) with 6, 11, 15, 16 months survival), i(21q) (two cases 42, 45 During the course of the disease karyotype evolution occurred in eight of our 26 patients with vivors group, P = 0.006), while monosomy 7 occurred in both these groups and also in the remaining patients. There were repeated chromosome examinations. Of these, five normal karyotypes evolved towards monosomy 7 (two cases), t(8;21), very few long survivors with RAEB ± T, while 10/17 poor survivors (Ͻ2 years) had RAEB ± T, and three in this group had +21, and a random anomaly (one case each), and a monosomy 7 case and a del(5q) case evolved to complex karyosecondary MDS. types. These chromosome changes occurred more often in CMML cases (P = 0.007). Karyotypic evolution in this series does not seem to confer a particularly adverse prognosis Concluding remarks (median survival: 32 months).
Our findings confirm the need for a worldwide accepted classification of childhood MDS, as for adult cases. Inclusion criteria should also be precisely defined, in order to reject
According to treatment cases with viral, toxic, or nutritional etiologies, and to include true MDS cases even when unclassifiable according to adult Idiopathic MDS: Half of the patients (13/25) have had BMT (Table 1) . Overall median survival was 2.5 years with or with-MDS criteria. MDS in childhood appear to be complex: genetic cases are out BMT. However, BMT was more often performed in patients with adverse prognostic factors (in 7/9 RAEB ± T and heterogeneous; each genetic pathogeny is poorly documented; recruitments are biased, and MDS frequency in each only in 6/16 cases without RAEB ± T, in 9/13 abnormal karyotypes vs 4/12 normal karyotypes). Median survival post-BMT disease unknown. Prognosis has still to be determined. Idiopathic cases also are likely to be heterogeneous, and genetic was 1.5 years, with six survivors out of 13 patients grafted.
Secondary MDS: BMT was done in all four patients, with backgrounds have to be uncovered in a number of cases. Malignant and non-malignant childhood MDS seem to exist three fatal outcomes 2, 10 and 16 months post-BMT, and one with 35 months+ survival from BMT.
(whether the term 'myelodysplasia' should be applied to all cases with given presenting cytological features or reserved Genetic cases: BMT was performed in only five patients, among whom are the three familial MDS and one Fanconi.
for malignant processes has been debated; 47,48 again, a large concensus will be needed). The latter, non-clonal MDS, are found in mitochondrial cytopathies, especially when RARS is diagnosed, and, maybe, in other genetic diseases. Our findAccording to survival ings that polyclonality was maintained in two patients with an apparently idiopathic MDS (ie an apparently malignant MDS) The overall 5-year survival rate was 38% in our study, 32% in Passmore et al, 7 and only 20% in a study where the most should prompt the assessment of clonality in cases with a normal karyotype. The concomitant elevated proliferation and aggressive FAB classes may have been over represented. 17 While median survival was 5 years at a previous date point apoptosis recently documented in adult MDS bone marrow by Raza et al 46 should also be tested in childhood MDS: different in our study, it dropped to only 3 years with a longer followup, this underlines: (1) that fallacious conclusions can be patterns, according to the pathogeny, could be found, giving
